James C. Crews
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
James C. Crews has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Robert S. Weller
2 shared publicationsAllen H. Hord
1 shared publicationCarmen Schatzman
1 shared publicationDonald D. Denson
1 shared publicationJ C. Gerancher
1 shared publicationJonathan Moss
1 shared publication
Latest Publications
- 1 July 2007
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (1) , 275-277
Pneumothorax After Coracoid Infraclavicular Brachial Plexus Block
Several variations on the technique for infraclavicular brachial plexus block have been described. The coracoid infraclavicular technique has become popular because of easily identified landmarks, reliable distribution of blockade, and low risk of respiratory complications such as pneumothorax. We report a case of pneumothorax in a patient after a coracoid infraclavicular brachial plexus block. Subtleties in landmark identification and measurement may affect the risk of pneumothorax.
- 1 July 2007
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (1) , 275-277
Pneumothorax After Coracoid Infraclavicular Brachial Plexus Block
Several variations on the technique for infraclavicular brachial plexus block have been described. The coracoid infraclavicular technique has become popular because of easily identified landmarks, reliable distribution of blockade, and low risk of respiratory complications such as pneumothorax. We report a case of pneumothorax in a patient after a coracoid infraclavicular brachial plexus block. Subtleties in landmark identification and measurement may affect the risk of pneumothorax.
- 1 April 2003
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 96 (4) , 1188-1190
Seizure After Levobupivacaine for Interscalene Brachial Plexus Block
This case report describes a patient who demonstrated generalized seizure activity after an injection of 30 mL of levobupivacaine 0.5% for interscalene brachial plexus block. No evidence of cardiovascular toxicity was noted.
- 1 April 2003
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 96 (4) , 1188-1190
Seizure After Levobupivacaine for Interscalene Brachial Plexus Block
This case report describes a patient who demonstrated generalized seizure activity after an injection of 30 mL of levobupivacaine 0.5% for interscalene brachial plexus block. No evidence of cardiovascular toxicity was noted.
- 7 August 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (5) , 629-632
Multimodal Pain Management Strategies for Office-Based and Ambulatory Procedures
Review from JAMA — Multimodal Pain Management Strategies for Office-Based and Ambulatory Procedures
- 7 August 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (5) , 629-632
Multimodal Pain Management Strategies for Office-Based and Ambulatory Procedures
Review from JAMA — Multimodal Pain Management Strategies for Office-Based and Ambulatory Procedures
- 1 July 2002
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 95 (1) , 219-223
Levobupivacaine for Axillary Brachial Plexus Block: A Pharmacokinetic and Clinical Comparison in Patients with Normal Renal Function or Renal Disease
We compared the pharmacokinetics and clinical characteristics of 0.5% levobupivacaine for axillary block in patients with normal renal function versus patients with end-stage renal disease (ESRD). Twenty patients with normal renal function and eight patients with ESRD received an axillary block with 50–60 mL of 0.5% levobupivacaine. Patients were evaluated for onset and duration of sensory/motor block. Eleven patients with normal renal function and eight patients with ESRD underwent pharmacokinetic analysis. No differences between groups were found in the onset, duration, or quality of block. The median time to sensory block was 12.5 min and 12.9 min, and mean duration of the block was 19 h and 22 h in normal versus ESRD patients, respectively. No significant differences in noncompartmental pharmacokinetic variables (median) were found between normal and ESRD patients with an AUC0-t (μg · h−1 · mL−1) of 11 and 13, peak concentration (Cmax) (μg/mL) of 1.2 and 1.6, and a time to peak concentration (Tmax) (min) of 55 and 48, respectively. This study demonstrates the clinical efficacy and equivalence of the pharmacokinetic characteristics of 0.5% levobupivacaine for axillary brachial plexus block in patients with ESRD and normal renal function.
- 1 July 2002
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 95 (1) , 219-223
Levobupivacaine for Axillary Brachial Plexus Block: A Pharmacokinetic and Clinical Comparison in Patients with Normal Renal Function or Renal Disease
We compared the pharmacokinetics and clinical characteristics of 0.5% levobupivacaine for axillary block in patients with normal renal function versus patients with end-stage renal disease (ESRD). Twenty patients with normal renal function and eight patients with ESRD received an axillary block with 50–60 mL of 0.5% levobupivacaine. Patients were evaluated for onset and duration of sensory/motor block. Eleven patients with normal renal function and eight patients with ESRD underwent pharmacokinetic analysis. No differences between groups were found in the onset, duration, or quality of block. The median time to sensory block was 12.5 min and 12.9 min, and mean duration of the block was 19 h and 22 h in normal versus ESRD patients, respectively. No significant differences in noncompartmental pharmacokinetic variables (median) were found between normal and ESRD patients with an AUC0-t (μg · h−1 · mL−1) of 11 and 13, peak concentration (Cmax) (μg/mL) of 1.2 and 1.6, and a time to peak concentration (Tmax) (min) of 55 and 48, respectively. This study demonstrates the clinical efficacy and equivalence of the pharmacokinetic characteristics of 0.5% levobupivacaine for axillary brachial plexus block in patients with ESRD and normal renal function.
- 1 June 2000
- Published by Elsevier in Anesthesiology Clinics of North America
- Vol. 18 (2) , 251-266
NEW DEVELOPMENTS IN EPIDURAL ANESTHESIA AND ANALGESIA
- 1 June 2000
- Published by Elsevier in Anesthesiology Clinics of North America
- Vol. 18 (2) , 251-266
NEW DEVELOPMENTS IN EPIDURAL ANESTHESIA AND ANALGESIA
- 1 June 2000
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 25 (3) , 313-317
Lateral cervical epidural catheter placement for continuous unilateral upper extremity analgesia and sympathetic block
Background and Objectives: The use of the laterally directed cervical epidural catheter for the treatment of acute and chronic pain has not been previously described. We have used this technique in a series of 30 patients to produce unilateral upper extremity analgesia and sympathetic block. We present a case report of a patient treated with this technique and a description of the technique and results from the series. Methods: We placed an epidural catheter at the C6-7 vertebral interspace and directed the needle bevel and catheter to the affected side in a woman with a history of complex regional pain syndrome of the right upper extremity. Results: We were able to show a unilateral block with this technique by anatomic parameters (unilateral contrast dye spread), physiologic parameters (unilateral Horner's syndrome), and symptomatic parameters (unilateral, subjective neural block). Although 1 patient treated with this technique had bilateral effects, no patient has had a predominant block on the contralateral side and there have been no complications. Conclusions: This case report shows results typical of this series of 30 patients. In this series, the laterally directed cervical epidural catheter was an effective technique to produce continuous unilateral analgesia and sympathetic block. Reg Aneth Pain Med 2000;25:313–317.
- 1 June 2000
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 25 (3) , 313-317
Lateral cervical epidural catheter placement for continuous unilateral upper extremity analgesia and sympathetic block
Background and Objectives: The use of the laterally directed cervical epidural catheter for the treatment of acute and chronic pain has not been previously described. We have used this technique in a series of 30 patients to produce unilateral upper extremity analgesia and sympathetic block. We present a case report of a patient treated with this technique and a description of the technique and results from the series. Methods: We placed an epidural catheter at the C6-7 vertebral interspace and directed the needle bevel and catheter to the affected side in a woman with a history of complex regional pain syndrome of the right upper extremity. Results: We were able to show a unilateral block with this technique by anatomic parameters (unilateral contrast dye spread), physiologic parameters (unilateral Horner's syndrome), and symptomatic parameters (unilateral, subjective neural block). Although 1 patient treated with this technique had bilateral effects, no patient has had a predominant block on the contralateral side and there have been no complications. Conclusions: This case report shows results typical of this series of 30 patients. In this series, the laterally directed cervical epidural catheter was an effective technique to produce continuous unilateral analgesia and sympathetic block. Reg Aneth Pain Med 2000;25:313–317.
- 1 December 1999
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (6) , 1504-9
A Comparison of the Analgesic Efficacy of 0.25% Levobupivacaine Combined with 0.005% Morphine, 0.25% Levobupivacaine Alone, or 0.005% Morphine Alone for the Management of Postoperative Pain in Patients Undergoing Major Abdominal Surgery
We compared the relative efficacy of the combination of the single-isomer local anesthetic levobupivacaine and the opioid analgesic morphine versus both drugs alone for postoperative epidural analgesia after major abdominal surgical procedures. Thoracic epidural anesthesia was produced and maintained with levobupivacaine 0.75% in combination with general inhaled anesthesia without opioids. Patients were randomized to one of three postoperative treatment groups: 1) a combination of levobupivacaine 0.25% and morphine 0.005%; 2) levobupivacaine 0.25%; or 3) morphine 0.005%. Postoperatively, all epidural infusions were commenced at a rate of 4 mL/h. Patients could receive a 4 mL-bolus dose and an increase in the epidural infusion rate by 2 mL/h on request for supplemental analgesia. Patients were also allowed ketorolac as a supplemental analgesic at any time after the first analgesic request. Patients in the combination group had longer times to request for supplemental analgesia as compared with the levobupivacaine only group (P < 0.05) and a trend toward longer time to request as compared with the morphine only group (P = 0.066). Patients in the combination group had lower visual analog scale pain scores at rest and activity at 4 and 8 h and fewer requests for supplemental ketorolac (P < 0.05). In conclusion, this study demonstrates a significant improvement in postoperative analgesic efficacy with the combination of levobupivacaine and morphine for continuous epidural analgesia after major abdominal surgical procedures. A significant improvement in postoperative analgesic efficacy is demonstrated with the thoracic epidural administration of the combination of the single-isomer local anesthetic levobupivacaine 0.25% and morphine 0.005% in patients after major abdominal surgical procedures as compared with either drug used alone.
- 1 December 1999
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (6) , 1504-9
A Comparison of the Analgesic Efficacy of 0.25% Levobupivacaine Combined with 0.005% Morphine, 0.25% Levobupivacaine Alone, or 0.005% Morphine Alone for the Management of Postoperative Pain in Patients Undergoing Major Abdominal Surgery
We compared the relative efficacy of the combination of the single-isomer local anesthetic levobupivacaine and the opioid analgesic morphine versus both drugs alone for postoperative epidural analgesia after major abdominal surgical procedures. Thoracic epidural anesthesia was produced and maintained with levobupivacaine 0.75% in combination with general inhaled anesthesia without opioids. Patients were randomized to one of three postoperative treatment groups: 1) a combination of levobupivacaine 0.25% and morphine 0.005%; 2) levobupivacaine 0.25%; or 3) morphine 0.005%. Postoperatively, all epidural infusions were commenced at a rate of 4 mL/h. Patients could receive a 4 mL-bolus dose and an increase in the epidural infusion rate by 2 mL/h on request for supplemental analgesia. Patients were also allowed ketorolac as a supplemental analgesic at any time after the first analgesic request. Patients in the combination group had longer times to request for supplemental analgesia as compared with the levobupivacaine only group (P < 0.05) and a trend toward longer time to request as compared with the morphine only group (P = 0.066). Patients in the combination group had lower visual analog scale pain scores at rest and activity at 4 and 8 h and fewer requests for supplemental ketorolac (P < 0.05). In conclusion, this study demonstrates a significant improvement in postoperative analgesic efficacy with the combination of levobupivacaine and morphine for continuous epidural analgesia after major abdominal surgical procedures. A significant improvement in postoperative analgesic efficacy is demonstrated with the thoracic epidural administration of the combination of the single-isomer local anesthetic levobupivacaine 0.25% and morphine 0.005% in patients after major abdominal surgical procedures as compared with either drug used alone.